ASSESSMENT OF FREQUENCY OF ALLOIMMUNIZATION AND ERYTHROCYTE AUTOIMMUNIZATION IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTS
Life-long red blood transfusion remains the main treatment for severe thalassemia. The development of hemolytic alloantibodies and erythrocyte autoantibodies complicated transfusion therapy in thalassemia patients. The frequency causes and prevention of this phenomenon among 80 transfused thalassemi...
Main Authors: | S. Ansari, P. Voosogh S. Moshtaghian |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2008-05-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5985.pdf&manuscript_id=5985 |
Similar Items
-
ASSESSMENT OF FREQUENCY OF ALLOIMMUNIZATION AND ERYTHROCYTE AUTOIMMUNIZATION IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTS
by: S. Ansari, et al.
Published: (2008-04-01) -
Trends of Erythrocyte Alloimmunization in Transfused Women
by: Sunia Ghaffar, et al.
Published: (2022-12-01) -
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
by: Hari Krishan Dhawan, et al.
Published: (2014-01-01) -
Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient
by: Joseph Philip, et al.
Published: (2014-01-01) -
Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
by: Satyam Arora, et al.
Published: (2021-01-01)